C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2001
11/22/2001	US20010044471 Hydrogenation of racemic 6-alkoxy-1H-indene-1,2(3H)-dione-2-oxime, with chiral acid, resolution, alkylation, bromination, carboxamidation
11/22/2001	US20010044420 Treatment of mammalian cancer
11/22/2001	US20010043935 Use of polyamino acid derivatives to treat seborrhoea and the associated skin disorders
11/22/2001	DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001	CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409063A1 7-substituted fused ring tetracycline compounds
11/22/2001	CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	CA2407099A1 Aralkyl ester soft drugs
11/21/2001	EP1155138A2 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154986A1 Process for the preparation of iopamidol
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323290A A process for the preparation of S-N,N'-bis [2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxyl-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzenedicarboxamide
11/21/2001	CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1075062C 乙酸衍生物 Acetic acid derivatives
11/20/2001	US6320064 Surfactants for aqueous cleaner systems for cleaning nontextile material with improved fat-removal capacity
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	CA2008116C Glycine derivatives
11/15/2001	WO2001085675A2 Fluorous tagging compounds and their use
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	US20010041814 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
11/15/2001	US20010041812 Cyclization using acyl halogenide; chemical intermediate
11/15/2001	DE10021900A1 New 2-aroyl-3-amino-alkenonitrile, amide and thioamide derivatives, useful as herbicides and pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or fungicides
11/15/2001	CA2408095A1 Fluorous tagging compounds and their use
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/14/2001	EP1153923A1 Process for the preparation of N-Carboxy-t-Leucine anhydride
11/14/2001	EP1153029A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents
11/14/2001	EP0815087B1 Trisubstituted phenyl derivatives
11/13/2001	US6316657 Process for purification or recovery of sweetener
11/13/2001	US6316595 PNA synthesis using a base-labile amino protecting group
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316440 Reduced dipeptide analogues as calcium channel antagonists
11/13/2001	CA2064793C Hydrolytic enzyme inhibitors and substrates and assays, methods and kits embodying same
11/08/2001	WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001	WO2001083424A1 Tertiary amine methacrylate-based macromonomers and polymers
11/08/2001	WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001	US20010039279 Diamide compounds and compositions containing the same
11/08/2001	US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001	DE10019755A1 New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1151997A1 Polychelants, their complexes with metal ions, their preparation and their uses
11/07/2001	EP1150943A1 Preparation of iodixanol
11/07/2001	EP1150942A1 Improved compounds for protein binding
11/07/2001	EP1003711B1 Novel lipopolyamines, and the preparation and use thereof
11/07/2001	CN1074460C Tetracycline fermentation process
11/06/2001	US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001	US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001	US6313146 Calcium receptor-active molecules
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001	US6313118 Hydroxytryptamine receptor antagonists
11/06/2001	US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/06/2001	US6312679 Dense star polymer conjugates as dyes
11/04/2001	CA2346149A1 Photo-reactive benzocyclobutenones and polymers therefrom for self-photocuring, photo-crosslinking and photopatterning without catalysts
11/03/2001	CA2307438A1 Tertiary amine methacrylate-based macromonomers and polymers
11/01/2001	WO2001081298A2 Cyclic carboxylic acids as integrin antagonists
11/01/2001	US20010037040 Acetamidobenzamide compounds for neurodegenerative disorders
11/01/2001	US20010036961 For protecting skeletal muscles against damage resulting from trauma or subsequent to muscle or systemic diseases such as intermittent claudication, for treating shock, cardiovascular disorders, for preserving donor tissue, organs in transplants
11/01/2001	US20010036927 Complexing
11/01/2001	US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection
10/2001
10/31/2001	EP1149843A1 Substituted phenethylamine derivatives
10/31/2001	EP0923537B1 Process for the preparation of contrast agents
10/30/2001	US6310243 Benzene compounds in which 3 non-adjacent ring atoms are substituted with iodine, 2 of the remaining ring atoms are amide substituted with hydroxy and the other remaining ring atom is a non-amide, hydroxy-substituted nonionic moiety
10/30/2001	US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001	US6310078 Substituted amino acids as erythropoietin mimetics
10/30/2001	US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001	US6310060 For use as antiproliferative agent for use against cancer, psoriasis, restenosis, autoimmune disease, or atherosclerosis
10/25/2001	WO2001079154A2 Synthesis of midodrine hci from a novel intermediate 1-(2',5'-dimethoxyphenyl)-2-azidoethanone
10/25/2001	WO2001078716A1 Solid dispersion with improved absorbability
10/25/2001	CA2407063A1 Solid dispersion with improved absorbability
10/24/2001	EP0820433B1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/24/2001	CN1073552C Benzamides for neurodegenerative disorder treatment
10/23/2001	US6307064 Process to prepare taxol
10/23/2001	US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306903 Alpha-aminoamide derivatives useful as analgesic agents
10/23/2001	US6306871 Iodonitrobenzamide derivatives as anticarcinogenic, antitumor agents and viricides
10/23/2001	US6306840 Cell adhesion inhibitors
10/23/2001	CA2083179C Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
10/23/2001	CA2062788C Improved process for preparing isepamicin
10/18/2001	WO2001077068A2 Process for preparing 6-aminocaproamide
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031865 Herbicides
10/18/2001	CA2403147A1 Process for preparing 6-aminocaproamide
10/17/2001	EP1144366A2 Use of androgen receptor suppressors
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144360A1 A method for the synthesis of compounds of formula 1 and derivatives thereof
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP0946497B1 Process for the preparation of nmda antagonists
10/17/2001	EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/16/2001	US6303819 Sodium channel-blocking agent; chronic or neuropathic pain.
10/16/2001	US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001	US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001	US6303569 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/16/2001	CA2178369C Process for the purification and crystallisation of iopamidol
10/11/2001	WO2001074761A1 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds

1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 162